✅ New CEO and Officers(8/23) ✅ Market Cap Only ~3m ✅ Secured a $1M line of credit: Non-Dilutive ✅ Filings: Pink Current ✅ Strong Inside Ownership ~90% ✅ ~400m Float ✅ Updates in the Pipeline - Steady updates/news ✅ 1.6B Shares Retired and reduced its preferred classes to three. ✅ 1.5B Reduction in Authorized Share Count ✅ No Convertible Notes ✅ Name and Symbol Change Coming! (Royal Biotek) ✅ Chart coming off solid bottom and 52-week low ✅ Recent acquisitions increasing revenues ✅ Affirms No Reverse Split (past split with old management) ✅ Expansion of Florida facility to nearly 11,000 square feet. ✅ 2022 Revenues Surpass 2021 by Over 335%
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.